Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Home > Cartherics News > Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Karen Loudon2019-01-23T23:36:03+11:00January 23rd, 2019|

April 8, 2022

Dr Ian Nisbet Chief Operating Officer Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner...

April 1, 2022

Alan Trounson is ranked among the world’s most prominent scientists

March 30, 2022

In the following interview with ARMI Alan Trounson discusses the importance and challenges of translation